Abstract

It is well established that L-proline has several roles in the biology of trypanosomatids. In Trypanosoma cruzi, the etiological agent of Chagas' disease, this amino acid is involved in energy metabolism, differentiation processes and resistance to osmotic stress. In this study, we analyzed the effects of interfering with L-proline metabolism on the viability and on other aspects of the T. cruzi life cycle using the proline analogue L- thiazolidine-4-carboxylic acid (T4C). The growth of epimastigotes was evaluated using different concentrations of T4C in standard culture conditions and at high temperature or acidic pH. We also evaluated possible interactions of this analogue with stress conditions such as those produced by nutrient starvation and oxidative stress. T4C showed a dose-response effect on epimastigote growth (IC50 = 0.89±0.02 mM at 28°C), and the inhibitory effect of this analogue was synergistic (p<0.05) with temperature (0.54±0.01 mM at 37°C). T4C significantly diminished parasite survival (p<0.05) in combination with nutrient starvation and oxidative stress conditions. Pre-incubation of the parasites with L-proline resulted in a protective effect against oxidative stress, but this was not seen in the presence of the drug. Finally, the trypomastigote bursting from infected mammalian cells was evaluated and found to be inhibited by up to 56% when cells were treated with non-toxic concentrations of T4C (between 1 and 10 mM). All these data together suggest that T4C could be an interesting therapeutic drug if combined with others that affect, for example, oxidative stress. The data also support the participation of proline metabolism in the resistance to oxidative stress.

Highlights

  • The protozoan parasite Trypanosoma cruzi is the causative agent of Chagas’ disease, which affects approximately 12–14 million people in endemic areas throughout Mexico, Central, and South America [1]

  • Growth inhibition assay L-proline, a relevant energy source in trypanosomatids, is metabolized and converted into five intermediates of the tricarboxylic acid cycle through its oxidation to glutamate in T. cruzi [4]

  • In order to investigate a possible trypanocide or trypanostatic effect of thiazolidine-4-carboxylic acid (T4C) on T. cruzi, 2.56106 epimastigotes per ml were cultured in the presence of different concentrations of T4C, ranging from 0.1 to 1 mM

Read more

Summary

Introduction

The protozoan parasite Trypanosoma cruzi is the causative agent of Chagas’ disease, which affects approximately 12–14 million people in endemic areas throughout Mexico, Central, and South America [1]. The observed growth differences between the treated cells and the LIT control were significant (p,0.01), and the IC50 was determined to be 0.8960.02 mM (Figure 1), demonstrating an effect of T4C on T. cruzi epimastigotes.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call